Elos Medtech Interim Report January 1 - March 31, 2023
January – March 2023 · Net sales for the first quarter amounted to SEK 267.2 (194.5) million, an increase of 37.4 percent compared to the same quarter last year. Net sales in local currencies increased by 29.5 percent. · Operating profit amounted to SEK 44.4 (29.2) million, corresponding to an operating margin of 16.6 (15.0) percent. · Profit after net financial items amounted to SEK 30.8 (29.8) million. Net financial items were negatively affected by exchange rate differences of SEK -4.7 (0.8) million and totaled SEK -13.6 (0.6) million. · Cash flow from operating activities